FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

PFIZER INC

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/3/2017 

3. Issuer Name and Ticker or Trading Symbol

ICU MEDICAL INC/DE [ICUI]

(Last)        (First)        (Middle)

235 E 42ND ST, 

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

NEW YORK, NY 10017       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   3200000   I   _   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  These shares are owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM are indirect beneficial owners of the shares.

Remarks:
Reporting Owner Name/Address/Relationship to Issuer: C.P. Pharmaceuticals International C.V. (CPPI), 235 E. 42nd, New York, NY 10017;10% Ownership; Pfizer Production LLC (PPL), 235 E. 42nd New York, NY 10017 10% Ownership*; Pfizer Manufacturing LLC (PML), 235 E. 42nd New York, NY 10017 10% Ownership*; Pfizer Inc., 235 E. 42nd New York, NY 10017 10% Ownership.
*Each of PPL and PML, as general partner of CPPI, disclaim ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
PFIZER INC
235 E 42ND ST
NEW YORK, NY 10017
X X

C.P. Pharmaceuticals International C.V.
C/O ITS GENERAL PARTNERS
235 E. 42ND ST
NEW YORK, NY 10017

X

Pfizer Production LLC
235 EAST 42ND STREET
NEW YORK, NY 10017

X

Pfizer Manufacturing LLC
235 EAST 42ND STREET
NEW YORK, NY 10017

X


Signatures
Pfizer Inc., By /s/ Susan Grant, Assistant Secretary 2/13/2017
** Signature of Reporting Person Date

Pfizer Production LLC, acting in its capacity as general partner of C.P. Pharmaceuticals International C.V. By /s/ Brian McMahon, Senior Vice President 2/13/2017
** Signature of Reporting Person Date

Pfizer Manufacturing LLC, acting in its capacity as general partner of C.P. Pharmaceuticals International C.V. By /s/ Colum Lane, Senior Vice President 2/13/2017
** Signature of Reporting Person Date

Pfizer Production LLC, By /s/Darren Welsh, Secretary 2/13/2017
** Signature of Reporting Person Date

Pfizer Manufacturing LLC, By /s/Darren Welsh, Secretary 2/13/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ICU Medical (NASDAQ:ICUI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more ICU Medical Charts.
ICU Medical (NASDAQ:ICUI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more ICU Medical Charts.